Drug maker Glenmark Pharmaceuticals today said its subsidiary has received US regulatory approval for

RELATED ARTICLES Glenmark Pharmaceuticals Q3 net dips 46.70% to Rs 46.11 cr Lupin gets USFDA approval for diabetes drug Fondaparinux injection issue resolved with USFDA: Dr Reddy's

marketing and distribution of Alclometasone Dipropionate Cream used to relieve certain types of itchy rashes, including psoriasis.

Glenmark Genercics Ltd, a subsidiary of the company, has received Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration for the cream to market and distribute the product in the US market immediately, Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange.

The product is targeted at a niche category in the dermatology segment and where competition is limited, the filing added.

The USFDA approval aligns with Glenmark's strategy to build on its established presence in the dermatology marketplace.